Lebriz Altay presenting SubLiminal laser for cCSC management at EURETINA 2019.
Yellow subthreshold laser vs pdt in eyes with CCSC
20/09/2019
Lihteh Wu presenting yellow subthreshold laser advantages versus PDT in eyes with CCSC at EURETINA 2019.
Subliminal laser for the treatment of Central Serous Chorioretinopathy
07/09/2019
Paula Scholz, M.D., FEBO, explains step by step, with her own experience, why subliminal laser therapy is an ideal treatment for Central Serous Chorioretinopathy.
Fovea-Involving DME: Reasons for the subliminal approach
07/09/2019
During EURETINA 2019, Alejandro Filloy Rius, MD Ph.D, talks about fovea involving DME and the reasons for the subliminal approach
SubLiminal Laser therapy
25/09/2018
Dr. Paula Scholz talks about SubLiminal laser therapy.
Treatment guidelines – Paula Scholz – Meeting Londres 2018
24/09/2018
Find out more about Subliminal treatment guidelines with Dr Paula Scholz.
Efficacy of SubLiminal laser in IPCV Aflibercept resistant cases
20/09/2018
During EURETINA 2018, Saad Younis makes a presentation on the safety and efficacy of SubLiminal Laser in Patients with Idiopathic Polypoidal Chroidal Vasculopathy Aflibercept resistant cases.
Our first year of lessons learnt with SubLiminal laser for CCSC and DME
20/09/2018
Alejandro Filloy Rius, MD Ph.D, explains the first year of lessons learnt with SubLiminal laser for CCSC and DME at EURETINA 2018.
Why consider the yellow 577nm wavelength?
05/12/2016
Giovanni Staurenghi, MD, explains why yellow 577nm laser is the wavelength of choice for retina treatments.
